CRISPR Therapeutics AG - Common Shares (NQ: CRSP )
49.72
+6.23
(+14.33%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 7,745,292 |
| Open | 46.21 |
| Bid (Size) | 49.73 (2) |
| Ask (Size) | 49.95 (3) |
| Prev. Close | 43.49 |
| Today's Range | 46.04 - 52.60 |
| 52wk Range | 36.52 - 91.10 |
| Shares Outstanding | 78,935,098 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
February 14, 2025
The Ultimate Healthcare Stock to Buy With $500 Right Now
February 14, 2025
Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
February 12, 2025
1 big new Green Flag for CRISPR Therapeutics' Stock
December 20, 2024
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
February 10, 2025
MaxCyte: Building the Future of Cell and Gene Therapy Innovation
January 23, 2025
My Top 5 Stocks to Buy in Early 2025
January 23, 2025
3 Unstoppable Stocks to Buy in 2025
January 18, 2025
2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
January 16, 2025
Vertex's Pain Drug: Big Pharma's Next Major Success?
January 16, 2025
My 10 Top Stocks to Buy to Start the New Year Off Right
January 16, 2025
3 Mid-Cap Stocks That Could Take Off in 2025
January 09, 2025
2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025
January 07, 2025
This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?
December 22, 2024
Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?
December 20, 2024
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.